Novo Nordisk’s Strategy in Winning Over GLP-1 Patients through Telehealth
Katie Palmer, the expert in telehealth, clinical artificial intelligence, and the health data economy, is all about exploring how digital health care impacts patients, providers, and businesses. You can hit her up on Signal...
Budget cuts impact Medicaid coverage for transgender healthcare services
So, like, hey there. Liz here, back again with another one of those articles that make you scratch your head and wonder what's going on. I mean, seriously, why does May in Boston feel...
Trump’s Drug Pricing Claims and FDA’s Covid Vaccine Directive: Pharmalittle Update
Ah, the end of another work week is nearly here. Can I get a hell yeah? It's time to start dreaming about our weekend plans, folks. As for me, I'm thinking about sprucing up...
Fluoride Debate in the U.S.: Insights from an Indian Dentist
Floriduh, the land of sun, sand, and now, no more fluoride in the water. Yup, you heard it right — Florida just hopped on the ban wagon, becoming the second state to kick fluoride...
New GSK Drug Approval Poses Competition for Dupixent
Sign up for our biotech newsletter to keep up with the latest in the science and politics driving the biotech industry. Sorry for the delay in getting this newsletter to you today - technical...
Latest Comings and Goings: Navigating Up and Down the Ladder
So, guess what? Got some new and exciting news to share? Hired someone fresh and promising? Finally filled that tough spot in the team? Well, don't keep it to yourself! We want to know...
Guidelines from FDA for Next Year’s Covid Vaccine Shot
Alright, so the Food and Drug Administration has given Covid vaccine manufacturers some new guidelines on what they should be targeting with next fall's vaccines. They basically want them to update the strain in...
FDA Advisory Panel Divided on Mandating Covid-19 Vaccine Updates
Alright, so the Food and Drug Administration’s expert vaccine panel had a bit of a disagreement on whether Covid-19 vaccine manufacturers should update the strain of the virus they are targeting in their products....
Sanofi Acquires New Alzheimer’s Drug: Expansion of Pipeline
Sanofi Snags Vigil Neuroscience for Alzheimer's DrugSo, like, Sanofi, the French drug maker, just dropped $470 million to acquire Vigil Neuroscience, a small biotech company. And get this, they're adding an experimental treatment for...
Understanding the Safety and Effectiveness of mRNA Vaccines: A Comprehensive Guide
So, like, mRNA vaccines were super crucial during the whole pandemic thing, right? They helped us combat the worst global crisis in, like, a century and even scored a Nobel Prize. But now, some...
Trump’s Drug Pricing Plan Update and Moderna’s Strategic Shift in Pharmalittle News
Well, hey there, folks! How's it going on this fine day? We're hanging in there, thank you very much, especially since we've hit the midpoint of the week. I mean, we've made it this...
LISA BLUNT ROCHESTER GRILLS RFK JR. ON CDC INTERIM DIRECTOR NOMINATION
Sen. Lisa Blunt Rochester shot off a fiery letter to Health Secretary Robert F. Kennedy Jr., demanding some answers about the Centers for Disease Control and Prevention's current leadership situation. She's not too thrilled...
